APRIL 8th 2016 Therapy 09.00-10.00 SESSION 1: Age-related Macular Degeneration Moderators: S. Sadda, D. Sarraf, K. Bailey Freund, E. Souied 09.00-09.15 Prospective SD OCT Analysis of PED Associated with Type 1 versus Type 3 Neovascularization in AMD D. Sarraf 09.15-09.30 Anti-PDGF and CNV fibrosis E. Souied 09.30-9.45 Optical Coherence Tomography Angiography reveals mature tangled vascular networks in eyes with neovascular AMD showing resistance to Geographic Atrophy K. Bailey Freund 9.45-10.00 Anti-VEGF therapy and atrophy: What s the connection S. Sadda 10.00-11.00 SESSION 2: Retinal Vascular Diseases I Moderators: N. Bressler, S. Bressler, M. Zarbin, R. Lattanzio 10.00-10.15 Protocol T N. Bressler 10.15-10.30 Statistical significance vs clinical importance: challenges in applying the results of clinical trials to clinical practice M. Zarbin 10.30-10.45 Diabetic Retinopathy S. Bressler 10.45-11.00 Vascular safety with ranibizumab in diabetic patients diagnosed with diabetic macular edema: a patient-level meta-analysis M. Zarbin 11.00-11.30 Coffee Break 11.30-12.30 SESSION 3: Retinal Vascular Diseases II and Other Retinal Disorders Moderators: A. Loewenstein, G. Coscas, R. Brancato, M. Varano
11.30-11.45 Intravitreal anti-vegf in Retinal Vein Occlusion G. Coscas 11.45-12.00 Intervitreal dexamethasone in Retinal Vascular Diseases A. Loewenstein 12.00-12.15 Long-lasting intravitreal fluocinolone in Retinal Vascular Diseases F. Bandello 12.15-12.30 Patients selection for Ocriplasmin injection L. Iuliano 12.30-14.00 The Lounge in the Forum (Lunch) 14.00-16.30 SESSION 4: CLINICAL CASES Panel: E. Souied, N. Bressler, S. Bressler, P. Rosenfeld, K. Bailey Freund, D. Sarraf, G. Coscas, S. Sadda, S. Sivaprasad, A. Gaudric, M. Zarbin, A. Loewenstein, J. Cunha-Vaz, U. Chakravarthy, J-F. Korobelnik, A. Giovannini, F. Parmeggiani, R. Rosa Discussion of Clinical Cases From speakers and attendees
APRIL 9th 2016 Imaging 09.00-10.30 SESSION 1: Age-related Macular Degeneration I Moderators: G. Querques, K. Bailey Freund, P. Rosenfeld, U. Menchini 09.00-09.10 Does Optical Coherence Tomography Angiography change our management of neovascular Age-related Macular Degeneration? P. Rosenfeld 09.10-09.20 OCT Angiography of quiescent Choroidal NeoVascularization G. Querques 09.20-09.30 Comparing Optical Coherence Tomography Angiography to Fluorescein Angiography for the Imaging of Type 1 Neovascularization (COFT-1 study) K. Bailey Freund 09.30-09.40 Perforating vessels in pathologic myopia F. Bandello 09.40-09.50 OCTA of Type 3 Neovascularization in AMD D. Sarraf 09.50-10.00 Optical Coherence Tomography Angiography: activity criteria G. Coscas 10.00-10.10 Comparisons of multimodal imaging in Age-related Macular Degeneration G. Coscas 10.10-10.20 Quantitative Optical Coherence Tomography Angiography S. Sadda 10.20-10.30 OCTA in myopic CNV J-F. Korobelnik 10.30-11.00 Coffee Break
11.00-12.30 SESSION 2: Retinal Vascular Diseases Moderators: A. Gaudric, P, Stanga, S. Sivaprasad 11.00-11.10 A non-invasive indirect identification of the sites of alterations of the Blood-Retinal Barrier J. Cunha-Vaz 11.10-11.20 Optical Coherence Tomography Angiography in retinal vein occlusions L. Mastropasqua 11.20-11.30 Microvascular retinal changes with OCT Angiography in diabetic retinopathy M. Parravano 11.30-11.40 Significance of DRIL in retinal vascular disorders S. Sivaprasad 11.40-11.50 En Face OCT and OCTA of the White Dot Syndromes D. Sarraf 11.50-12.00 Optical Coherence Tomography Angiography in neovascular macular telangiectasis type 2 P. Rosenfeld 12.00-12.10 Optical Coherence Tomography Angiography findings in Diabetic Macular Edema A. Gaudric 12.10-12.20 OCT in sickle cell retinopathy F. Viola 12.20-12.30 Quantification of capillary closure J. Cunha-Vaz 12.30-14.00 The Lounge in the Forum (Lunch)
14.00-15.30 SESSION 3: Age-related Macular Degeneration II and other retinal disorders I Moderators: D. Sarraf, G. De Crecchio, G. Querques, U. Chakravarthy 14.00-14.10 Optical Coherence Tomography Angiography in dry Age-related Macular Degeneration P. Rosenfeld 14.10-14.20 Optical Coherence Tomography Angiography characterization of macular atrophy G. Staurenghi 14.20-14.30 Optical Coherence Tomography Angiography in CSR A. Loewenstein 14.30-14.40 Multimodal imaging of the pachychoroid spectrum K. Bailey Freund 14.40-14.50 Optical Coherence Tomography in Best Vitelliform Macular Dystrophy M. Battaglia Parodi 14.50-15.00 Optical Coherence Tomography in Pigment Epithelium Detachment U. Introini 15.00-15.10 Multimodal imaging correlates of hyper reflective material on tomography U. Chakravarthy 15.10-15.20 Optical Coherence Tomography Angiography in Myopic macular degeneration A. Pece 15.20-15.30 Discussion 15.30-16.00 Coffee Break 16.00 17.30 SESSION 4: Other retinal disorders II Moderators: T. Avitabile, F. Bandello, G. Guarnaccia 16.00-16.10 Swept source in vitreoretinal surgery S. Rizzo 16.10-16.20 Retina layers restoration in macular hole surgery C. Azzolini
16.20-16.30 Optical Coherence Tomography Angiography findings in full thickness and lamellar macular holes L. Pierro 16.30-16.40 Geographic atrophy: en-face OCT vs fundus autofluorescence E. Midena 16.40-16.50 Structure and function of RGCs in optic neuropathies P. Barboni 16.50-17.00 Pitfalls of Optical Coherence Tomography Angiography P. Lanzetta 17.00-17.10 Optical Coherence Tomography findings in rat model of Retinal Angiomatous Proliferation G. Zerbini 17.10-17.20 New Evidences on Neuroprotective Effect of Citicoline Eye Drops in Diabetic Retinopathy F. Bandello 17.20-17.30 Discussion 17.30 End of the Congress